| Year |
Citation |
Score |
| 2020 |
Andreadou I, Bell RM, Bøtker HE, Zuurbier CJ. SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical models. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 165770. PMID 32194159 DOI: 10.1016/j.bbadis.2020.165770 |
0.328 |
|
| 2016 |
Cohen MV, Yang XM, White J, Yellon DM, Bell RM, Downey JM. Cangrelor-Mediated Cardioprotection Requires Platelets and Sphingosine Phosphorylation. Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy. PMID 26780906 DOI: 10.1007/s10557-015-6633-2 |
0.318 |
|
| 2015 |
Rossello X, Hall AR, Bell RM, Yellon DM. Characterization of the Langendorff Perfused Isolated Mouse Heart Model of Global Ischemia-Reperfusion Injury: Impact of Ischemia and Reperfusion Length on Infarct Size and LDH Release. Journal of Cardiovascular Pharmacology and Therapeutics. PMID 26353758 DOI: 10.1177/1074248415604462 |
0.502 |
|
| 2013 |
Bell RM, Kunuthur SP, Hendry C, Bruce-Hickman D, Davidson S, Yellon DM. Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection. Basic Research in Cardiology. 108: 331. PMID 23361433 DOI: 10.1007/s00395-013-0331-7 |
0.375 |
|
| 2007 |
Bell RM, Clark JE, Hearse DJ, Shattock MJ. Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: Characterisation in the bi-phasic profile of early and late protection. Cardiovascular Research. 73: 153-63. PMID 17126307 DOI: 10.1016/J.Cardiores.2006.10.013 |
0.53 |
|
| 2005 |
Bell RM, Cave AC, Johar S, Hearse DJ, Shah AM, Shattock MJ. Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 2037-9. PMID 16236999 DOI: 10.1096/Fj.04-2774Fje |
0.559 |
|
| 2005 |
Eaton P, Bell RM, Cave AC, Shattock MJ. Ischemic preconditioning: a potential role for protein S-thiolation? Antioxidants & Redox Signaling. 7: 882-8. PMID 15998243 DOI: 10.1089/ars.2005.7.882 |
0.536 |
|
| 2003 |
Bell RM, Yellon DM. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. Journal of Molecular and Cellular Cardiology. 35: 185-93. PMID 12606259 DOI: 10.1016/S0022-2828(02)00310-3 |
0.445 |
|
| 2002 |
Mocanu MM, Bell RM, Yellon DM. PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. Journal of Molecular and Cellular Cardiology. 34: 661-8. PMID 12054853 DOI: 10.1006/jmcc.2002.2006 |
0.368 |
|
| Show low-probability matches. |